3rd Quarter - Report
FORBES-TATE for ALLERGAN USA, INC.
Firm
Client
Income
$120,000
Expenses
—
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Issues related to corporate tax reform; issues related to tax inversions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN BUSCHER New | — |
| JERRY DRISCOLL | — |
| JEFFREY FORBES | — |
| ELIZABETH GREER | — |
| RACHEL MILLER | — |
| DANIEL C TATE | — |
| WESLEY RYAN WELCH | — |
| ZACHARY WILLIAMS | — |
Medicare/Medicaid MMM
Issues related to drug approval.Issues related to FDA draft guidances.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN BUSCHER New | — |
| JERRY DRISCOLL | — |
| JEFFREY FORBES | — |
| ELIZABETH GREER | — |
| RACHEL MILLER | — |
| DANIEL C TATE | — |
| WESLEY RYAN WELCH | — |
| ZACHARY WILLIAMS | — |
Labor Issues/Antitrust/Workplace LBR
Issues related to antitrust.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN BUSCHER New | — |
| JERRY DRISCOLL | — |
| JEFFREY FORBES | — |
| ELIZABETH GREER | — |
| RACHEL MILLER | — |
| DANIEL C TATE | — |
| WESLEY RYAN WELCH | — |
| ZACHARY WILLIAMS | — |
Health Issues HCR
Issues related to pharmaceutical reimbursement; issues related to intellectual property and drug counterfeiting; issues related to Restastis.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN BUSCHER New | — |
| JERRY DRISCOLL | — |
| JEFFREY FORBES | — |
| ELIZABETH GREER | — |
| RACHEL MILLER | — |
| DANIEL C TATE | — |
| WESLEY RYAN WELCH | — |
| ZACHARY WILLIAMS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.